Will Mc Aree
About Will Mc Aree
Will Mc Aree is a Senior Director of Regulatory Affairs at Kite Pharma, where he has worked since 2020. He has extensive experience in regulatory affairs, having held various positions at notable companies including Gilead Sciences and Alnylam Pharmaceuticals.
Current Position at Kite Pharma
Will Mc Aree serves as the Senior Director of Regulatory Affairs at Kite Pharma, a role he has held since 2020. He is based in London, England, United Kingdom. In this position, he oversees regulatory strategies and ensures compliance with industry regulations, contributing to the development and approval of innovative therapies.
Previous Roles at Kite Pharma
Will Mc Aree previously worked at Kite Pharma in two capacities. He served as Associate Director of Regulatory Affairs for three months in 2018 and then as Director of Regulatory Affairs from 2018 to 2020. During his tenure, he played a significant role in regulatory submissions and interactions with health authorities.
Experience at Gilead Sciences
Will Mc Aree has extensive experience at Gilead Sciences, where he held multiple positions. He worked as Senior Manager of Regulatory Affairs from 2016 to 2017, Manager of Regulatory Affairs from 2014 to 2016, and Manager of Medical Affairs from 2013 to 2014. His roles involved managing regulatory submissions and supporting product development initiatives.
Educational Background
Will Mc Aree studied Biomedical Sciences at the University of Southampton, where he earned a Bachelor of Science (BSc) degree from 1998 to 2001. This educational foundation provided him with the knowledge necessary for his career in regulatory affairs within the pharmaceutical industry.
Early Career and Other Positions
Will Mc Aree began his career as a Laboratory Scientist at Anthony Nolan from 2001 to 2002. He later held various regulatory affairs roles at Sanofi Pasteur MSD and Alnylam Pharmaceuticals, including Regulatory Affairs Executive and Associate Director of Regulatory Affairs, respectively. His diverse experience has contributed to his expertise in regulatory compliance and strategy.